TRAIL induced survival and proliferation in cancer cells resistant towards TRAIL-induced apoptosis mediated by NF-κB

Oncogene

Volumn 22, Issue 25, 2003, Pages 3842-3852

  Ehrhardt, Harald ^a   Fulda, Simone ^b   Schmid, Irene ^a   Hiscott, John ^c   Debatin, Klaus Michael ^b   Jeremias, Irmela ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Apoptosis resistance; NF B; Proliferation; Survival; TRAIL

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 8; DOXORUBICIN; I KAPPA B ALPHA; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEASOME INHIBITOR; STAUROSPORINE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ACUTE LEUKEMIA; ADOLESCENT; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL COUNT; CELL PROLIFERATION; CELL SURVIVAL; CHILD; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LEUKEMIA CELL; LEUKEMIA CELL LINE; MALE; MITOGENESIS; PRIORITY JOURNAL;

ACUTE DISEASE; ADOLESCENT; ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL DIVISION; CELL SURVIVAL; CHILD; CHILD, PRESCHOOL; CYSTEINE ENDOPEPTIDASES; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; I-KAPPA B KINASE; JURKAT CELLS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOID; MALE; MEMBRANE GLYCOPROTEINS; MULTIENZYME COMPLEXES; NF-KAPPA B; PROTEASE INHIBITORS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN-SERINE-THREONINE KINASES; PROTEINS; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0038339094     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206520     Document Type: Article

References (20)

1. Baetu TM, Kwon H, Sharma S, Grandvaux N and Hiscott J. (2001). J. Immunol., 167, 3164-3173.
2. Budd RC. (2002). J. Clin. Invest., 109, 437-442.
3. Fulda S and Debatin KM. (2002). Oncogene, 21, 2295-2308.
4. Harhaj EW, Good L, Xiao G, Uhlik M, Cvijic ME, Rivera-Walsh I and Sun SC. (2000). Oncogene, 19, 1448-1456.
5. Herr I, Wilhelm D, Meyer E, Jeremias I, Angel P and Debatin KM. (1999). Cell Death Differ., 6, 130-135.
6. Hueber AO, Zornig M, Bernard AM, Chautan M and Evan G. (2000). J. Biol. Chem., 275, 10453-10462.
7. Jeremias I, Kupatt C, Baumann B, Herr I, Wirth T and Debatin KM. (1998a). Blood, 91, 4624-4631.
8. Jeremias I, Herr I, Boehler T and Debatin KM. (1998b). Eur. J. Immunol., 28, 143-152.
9. Juo P, Kuo CJ, Yuan J and Blenis J. (1998). Curr. Biol., 8, 1001-1008.
10. Karin M, Cao Y, Greten FR and Li ZW. (2002). Nat. Rev. Cancer, 2, 301-310.
11. Krammer PH. (2000). Nature, 407, 789-795.
12. Kupatt C, Habazettl H, Goedecke A, Wolf DA, Zahler S, Boekstegers P, Kelly RA and Becker BF. (1999). Circ. Res., 84, 392-400.
13. Lin Y, Devin A, Cook A, Keane MM, Kelliher M, Lipkowitz S and Liu ZG. (2000). Mol. Cell. Biol., 20, 6638-6645.
14. Mapara MY, Bargou R, Zugck C, Dohner H, Ustaoglu F, Jonker RR, Krammer PH and Dorken B. (1993). Eur. J. Immunol., 23, 702-708.
15. Muhlenbeck F, Haas E, Schwenzer R, Schubert G, Grell M, Smith C, Scheurich P and Wajant H. (1998). J. Biol. Chem., 273, 33091-33098.
16. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F and Riccardi C. (1991). J. Immunol. Methods, 139, 271-279.
17. Scaffidi C, Schmitz I, Krammer PH and Peter ME. (1999). J. Biol. Chem., 274, 1541-1548.
18. Teitz T, Wei T, Valentine MB, Vanin EF, Grenet J, Valentine VA, Behm FG, Look AT, Lahti JM and Kidd VJ. (2000). Nat. Med., 6, 529-535.
19. Thilenius ARB, Braun K and Russell JH. (1997). Eur. J. Immunol., 27, 1108-1114.
20. Ting AT, Pimentel-Muinos FX and Seed B. (1996). EMBO J., 15, 6189-6196.